LIH-PREDI-COVID

PREDI-COVID participants` samples and data for COVIRNA


Primary Purpose
the samples to be used within COVIRNA were collected as part of the clinical study registered with the "ClinicalTrials.gov Identifier: NCT04332094". Randomized Interventional Pilot Phase II Clinical Trial; SARS-CoV-2 infection; Primary outcomes: mechanical ventilation, In-hospital mortality.
Study Types
PREDI-COVID participants` samples and data for COVIRNA
Description of Cohorts
COVID-19 infected patients with various degrees of severity from Luxembourg.
Informed Consent Given?
True
Multi-center Study?
True
Organisms
Homo sapiens
Number of subjects
167
Diseases
COVID-19
Sample Sources
-
Type of Samples Collected
Plasma
Age Range of Study Participants
-
BMI Range of Study Participants
-